Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LTI-01 by Aileron Therapeutics for Empyema: Likelihood of Approval
LTI-01 is under clinical development by Aileron Therapeutics and currently in Phase II for Empyema. According to GlobalData, Phase II...